Mineralys Therapeutics
LightNews LightNews
banner
mineralystx.com
Mineralys Therapeutics
@mineralystx.com
49 followers 250 following 22 posts
We're a public, clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for hypertension.

mineralystx.com
Posts Replies Media Videos
mineralystx.com
In addition, our pivotal Phase 3 Launch-HTN trial was featured in the “Best of the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM)” session.

@asnkidney.bsky.social
@jama.com

#Hypertension #CKD #CardioRenalMetabolic
#NephSky #CardioSky
jama.com JAMA @jama.com · Jun 30
In this pivotal phase 3 RCT, lorundrostat lowered blood pressure in adults with uncontrolled or treatment-resistant hypertension on multiple antihypertensive medications.

#MedSky #RCT

https://ja.ma/4nvMfbu
Figure 2. Changes in Office Blood Pressure From Randomization (Baseline) toWeek 6
November 7, 2025 at 11:29 PM
mineralystx.com
Data from the Phase 3 Launch-HTN trial of lorundrostat will be featured during a session tomorrow highlighting the most impactful #kidney research articles recently published in @jama.com & @nejm.org.

#NephSky #CardioSky
Best of JAMA & NEJM JAMA: Lorundrostat in Participants with Uncontrolled Hypertension and Treatment-Resistant Hypertension - The Launch-HTN Randomized Clinical Trial PRESENTER: Manish Saxena, MBBS, MSc November 7th | 2:00 PM to 2:20 PM CST Grand Ballroom A, Convention Center
November 6, 2025 at 9:47 PM
mineralystx.com
#HighBloodPressure #CKD #OSA #CardioSky #NephSky
September 8, 2025 at 12:37 PM
mineralystx.com
#HighBloodPressure #CardiovascularDisease #CKD #OSA #CardioSky #NephSky
September 4, 2025 at 8:18 PM
mineralystx.com
📌
August 30, 2025 at 11:57 AM
mineralystx.com
#MedSky #EndoSky #CardioSky #Nephsky
June 17, 2025 at 1:28 PM